688289 圣湘生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.6972.7713.8164.94827.929
总资产报酬率 ROA (%)0.5202.1953.2314.12723.817
投入资产回报率 ROIC (%)0.5622.3953.6274.84527.468

边际利润分析
销售毛利率 (%)73.31475.78677.91271.53958.834
营业利润率 (%)11.90512.38319.05142.44436.274
息税前利润/营业总收入 (%)9.9276.76212.02435.45035.123
净利润/营业总收入 (%)9.5569.37715.51934.57130.025

收益指标分析
经营活动净收益/利润总额(%)124.174140.07768.9616.158109.765
价值变动净收益/利润总额(%)-13.200-3.806-7.84276.8813.422
营业外收支净额/利润总额(%)-1.863-16.099-6.587-4.138-1.031

偿债能力分析
流动比率 (X)4.2634.3737.6706.4734.788
速动比率 (X)3.8974.0307.1506.0634.562
资产负债率 (%)24.74624.52714.62212.17518.106
带息债务/全部投入资本 (%)17.66117.3065.8471.0500.483
股东权益/带息债务 (%)455.967467.0451,587.0209,285.78020,361.485
股东权益/负债合计 (%)301.355304.552575.768699.630451.575
利息保障倍数 (X)-5.638-1.732-2.056-6.679-44.984

营运能力分析
应收账款周转天数 (天)132.683126.189150.476351.35157.791
存货周转天数 (天)330.334365.202430.019459.63549.133